Protean eGov (PROTEAN)

FairStock Score: 21/100 — RISKY

Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

Strengths

• Low leverage: Debt/Equity of 0.07 gives balance sheet resilience
• Piotroski F-Score of 7/9 indicates solid fundamentals and no severe distress
• Double-digit growth: sales up 13.13% and profit up 10.82%
• Modest dividend yield of 1.69% with a conservative capital structure
• Current price is near the lower end of the 52-week range, offering a starting point for research

Concerns

• Zero promoter holding means no skin in the game and potential governance risk
• P/E of 25.63 and PEG of 2.14 make valuation rich for ~11% profit growth
• Profit growth of 10.82% lags sales growth of 13.13%, signalling margin pressure
• FairStock Score of 23/100 and stock 43% below its 52-week high suggest risk of a value trap

AI Analysis

Protean eGov looks like a steady IT-enabled services firm at first glance: minimal debt of 0.07 times equity, a Piotroski score of 7/9, and no signs of financial distress. But I am not looking for a merely adequate business; I am looking for an undervalued one. At ₹537.65, the market cap is ₹2,397 Cr, which translates to a P/E of 25.63. For a company earning profit growth of 10.82%, that is expensive; the PEG ratio of 2.14 confirms it. Sales did grow 13.13%, but profit grew slower, so operating leverage is not working in shareholders' favour. The latest quarter shows sales of ₹229 Cr and net profit of ₹23 Cr—a thin margin for the risk an equity holder takes. Book value is ₹237.26, yet the stock trades at 2.27 times book; with ROE of only 9.98%, I am paying a rich premium for modest returns. ROCE of 11.72% also does not suggest a wide economic moat. Worse, promoter holding is 0.00%—there is no owner-operator to align with minority shareholders. The stock has fallen from a 52-week high of ₹945.50 to ₹537.65, but a falling knife is not necessarily a bargain. A dividend yield of 1.69% provides some comfort, but the FairStock Score of 23/100 labels this as risky. Graham said price is what you pay, value is what you get; here, I get a slow-growing business with mediocre returns at an average-to-rich multiple. I need a wider margin of safety—either a lower price, higher returns on capital, or evidence of a durable moat. Without those, I cannot comfortably compound my capital in Protean eGov today.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer